Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
Avarol
180
CHF
CHF 180.00
In stock
AG-CN2-0044-M0011 mgCHF 180.00
| Product Details | |
|---|---|
| Synonyms | NSC 306951 |
| Product Type | Chemical |
| Properties | |
| Formula |
C21H30O2 |
| MW | 314.5 |
| CAS | 55303-98-5 |
| Source/Host Chemicals | Isolated from sponge Dysidea avara. |
| Purity Chemicals | ≥97% (HPLC) |
| Appearance | Off-white solid. |
| Solubility | Soluble in ethanol or DMSO. |
| Identity | Determined by 1H-NMR. |
| InChi Key | JSPUCPNQXKTYRO-LWILDLIXSA-N |
| Smiles | [H][C@@]12CCC=C(C)[C@@]1(C)CC[C@H](C)[C@@]2(C)CC1=CC(O)=CC=C1O |
| Shipping and Handling | |
| Shipping | AMBIENT |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Handling Advice |
Keep cool and dry. Protect from light. |
| Use/Stability |
Stable for at least 2 years after receipt when stored at -20°C. Store solutions at -20°C in the dark. |
| Documents | |
| MSDS |
 Download PDF |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
Description
- Antibacterial against selected Gram-positive strains, antifungal [1, 6].
- Anticancer compound [2].
- Antileukemic [4, 5, 8, 9].
- Antimitotic agent [3].
- Antiviral compound [7, 8, 14].
- Inhibits HIV activity [7, 8, 14].
- Anti-inflammatory [10, 12].
- Synovial phospholipase A2, cyclooxygenase and lipoxygenase inhibitor [10, 12].
- Modulator of superoxide dismutase and glutathione peroxidase [11].
- Platelet aggregation inhibitor [13].
- Anti-psoriatic [15, 17], mediated by inhibition of TNF-α generation and NF-κB activation [18, 19].
- Reviews [16, 20].
Product References
- Antimicrobial activity of avarol, a sesquiterpenoid hydroquinone from the marine sponge, Dysidea avara: L. Cariello, et al.; Comp. Biochem. Physiol. B. 71, 281 (1982)
- Avarol, a cytostatically active compound from the marine sponge Dysidea avara: W.E. Müller, et al.; Comp. Biochem. Physiol. C. 80, 47 (1985)
- Inhibition of mitosis by avarol, a natural product isolated from the sponge Dysidea avara: W.E. Müller, et al.; Basic Appl. Histochem. 29, 321 (1985)
- Potent antileukemic activity of the novel cytostatic agent avarone and its analogues in vitro and in vivo: W.E. Müller, et al.; Cancer Res. 45, 4822 (1985)
- Antimutagenic activity of the novel antileukemic agents, avarone and avarol: B. Kurelec, et al.; Mutat. Res. 144, 63 (1985)
- Antibacterial and antifungal activity of Avarone and Avarol: G. Seibert, et al.; Zentralbl. Bakteriol. Mikrobiol. Hyg. A. 260, 379 (1985)
- Inhibition of replication of the etiologic agent of acquired immune deficiency syndrome (human T-lymphotropic retrovirus/lymphadenopathy-associated virus) by avarol and avarone: P.S. Sarin, et al.; J. Natl. Cancer Inst. 78, 663 (1987)
- Influence of the antileukemic and anti-human immunodeficiency virus agent avarol on selected immune responses in vitro and in vivo: W.E. Müller, et al.; Biochem. Pharmacol. 36, 1489 (1987)
- Avarol-induced DNA strand breakage in vitro and in Friend erythroleukemia cells: W.E. Müller, et al.; Cancer Res. 47, 6565 (1987)
- Induction of gamma-interferon by avarol in human peripheral blood lymphocytes: R. Voth, et al.; Jpn. J. Cancer Res. 79, 647 (1988)
- Action of the antileukemic and anti-HTLV-III (anti-HIV) agent avarol on the levels of superoxide dismutases and glutathione peroxidase activities in L5178y mouse lymphoma cells: E. Batke, et al.; Cell Biochem. Funct. 6, 123 (1988)
- Avarol and avarone, two new anti-inflammatory agents of marine origin: M.L. Ferrandiz, et al.; Eur. J. Pharmacol. 253, 75 (1994)
- In vitro effect of avarone and avarol, a quinone/hydroquinone couple of marine origin, on platelet aggregation: M.A. Belisario, et al.; Pharmacol. Toxicol. 79, 300 (1996)
- Natural products with anti-HIV activity from marine organisms: L.A. Tziveleka, et al.; Curr. Top. Med. Chem. 3, 1512 (2003) (Review)
- Potential antipsoriatic avarol derivatives as antioxidants and inhibitors of PGE(2) generation and proliferation in the HaCaT cell line: M. Amigo, et al.; J. Nat. Prod. 67, 1459 (2004)
- Reactivity and biological activity of the marine sesquiterpene hydroquinone avarol and related compounds from sponges of the order Dictyoceratida: D. Sladic & M.J. Gasic; Molecules 11, 1 (2006)
- Identification of avarol derivatives as potential antipsoriatic drugs using an in vitro model for keratinocyte growth and differentiation: M. Amigó, et al.; Life Sci. 79, 2395 (2006)
- Antipsoriatic effects of avarol-3'-thiosalicylate are mediated by inhibition of TNF-alpha generation and NF-kappaB activation in mouse skin: M Amigó, et al.; Br. J. Pharmacol. 152, 353 (2007)
- Avarol inhibits TNF-alpha generation and NF-kappaB activation in human cells and in animal models: M. Amigó, et al.; Life Sci. 82, 256 (2008)
- Cytotoxic terpene quinones from marine sponges: M. Gordaliza; Mar. Drugs 8, 2849 (2010)
- Avarol induces apoptosis in pancreatic ductal adenocarcinoma cells by activating PERK–eIF2α–CHOP signaling: T. Namba & R. Kodama; Mar. Drugs 13, 2376 (2015)